Business Context and Reporting Period
Company: Wearable Devices Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Date: September 15, 2025
Principal Executive Offices: Yokne-am Illit, Israel
Context: The filing discloses the entry into a Securities Purchase Agreement on September 12, 2025, for a registered direct offering and concurrent private placement of securities to a single institutional investor.
Key Financial Metrics and Transaction Details
Transaction Overview: The Company agreed to issue and sell securities in a registered direct offering and concurrent private placement.
- Ordinary Shares: 440,000 shares at $6.00 per share.
- Pre-Funded Warrants: Warrants to acquire up to 230,000 Ordinary Shares at $5.9999 per warrant (exercise price $0.0001).
- Ordinary Warrants: Warrants to acquire up to 670,000 Ordinary Shares at $6.00 per share (expiring September 16, 2030).
- Placement Agent Fees: 7.0% placement fee and 1.0% management fee on aggregate gross proceeds.
- Expense Reimbursement: Up to $50,000 for legal and other expenses.
Financial Performance: The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on the capital raise transaction.
Material Changes and Restrictions
Beneficial Ownership Limitation: Pre-Funded Warrants were utilized to prevent the Purchaser from beneficially owning more than 9.99% of the outstanding share capital immediately following the offering.
Lock-Up Provisions: Unless waived by the Purchaser, the Company is restricted for 60 days from the closing date from:
- Issuing or announcing the issuance of Ordinary Shares or equivalent securities.
- Filing registration statements (with specific exceptions for Form S-8, ATM facilities, and resale registrations).
- Conducting variable rate transactions.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release titled "Wearable Devices Announces Pricing of $4 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules."
Forward-Looking Statements: The document contains forward-looking statements regarding the closing of the offering and future business strategies. These are based on current beliefs and are subject to inherent uncertainties.
Risks and Contingencies: Actual results may differ materially from forward-looking statements due to risks described in the Company's Form 20-F for the year ended December 31, 2024. The Company undertakes no obligation to update these statements.
Investor Verification Checklist
- Verify the final closing date and actual gross proceeds raised from the offering.
- Confirm the identity of the institutional Purchaser and their post-offering beneficial ownership percentage.
- Review the effective status of the Form F-3 registration statement for the Ordinary Warrants (required within 15-90 days).
- Assess the impact of the 60-day lock-up period on the Company's ability to raise additional capital.
- Examine the Company's most recent Form 20-F (filed March 20, 2025) for detailed financial health and risk factors not included in this 6-K.